<?xml version="1.0" encoding="utf-8"?>
<TEI xmlns="http://www.tei-c.org/ns/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:hal="http://hal.archives-ouvertes.fr/" xmlns:gml="http://www.opengis.net/gml/3.3/" xmlns:gmlce="http://www.opengis.net/gml/3.3/ce" version="1.1" xsi:schemaLocation="http://www.tei-c.org/ns/1.0 http://api.archives-ouvertes.fr/documents/aofr-sword.xsd">
  <teiHeader>
    <fileDesc>
      <titleStmt>
        <title>HAL TEI export of inserm-01463679</title>
      </titleStmt>
      <publicationStmt>
        <distributor>CCSD</distributor>
        <availability status="restricted">
          <licence target="https://creativecommons.org/publicdomain/zero/1.0/">CC0 1.0 - Universal</licence>
        </availability>
        <date when="2026-05-19T06:05:09+02:00"/>
      </publicationStmt>
      <sourceDesc>
        <p part="N">HAL API Platform</p>
      </sourceDesc>
    </fileDesc>
  </teiHeader>
  <text>
    <body>
      <listBibl>
        <biblFull>
          <titleStmt>
            <title xml:lang="en">Editorial: innovative radiopharmaceuticals in oncology and Neurology</title>
            <author role="aut">
              <persName>
                <forename type="first">Jacques</forename>
                <surname>Barbet</surname>
              </persName>
              <idno type="halauthorid">301813-0</idno>
              <affiliation ref="#struct-545604"/>
              <affiliation ref="#struct-477534"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Nicolas</forename>
                <surname>Arlicot</surname>
              </persName>
              <idno type="halauthorid">719895-0</idno>
              <affiliation ref="#struct-53727"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Marie-Hélène</forename>
                <surname>Gaugler</surname>
              </persName>
              <email type="md5">d355d2436b955635be02313277c2dc81</email>
              <email type="domain">univ-nantes.fr</email>
              <idno type="idhal" notation="string">marie-helene-gaugler</idno>
              <idno type="idhal" notation="numeric">1444588</idno>
              <idno type="halauthorid" notation="string">1038911-1444588</idno>
              <idno type="ORCID">https://orcid.org/0000-0003-2932-9443</idno>
              <affiliation ref="#struct-477534"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Michel</forename>
                <surname>Chérel</surname>
              </persName>
              <email type="md5">faa80347e497f8eeeb8a12647a37d2d5</email>
              <email type="domain">univ-nantes.fr</email>
              <idno type="idhal" notation="string">michel-cherel</idno>
              <idno type="idhal" notation="numeric">752010</idno>
              <idno type="halauthorid" notation="string">34807-752010</idno>
              <idno type="ORCID">https://orcid.org/0000-0001-6347-6848</idno>
              <idno type="IDREF">https://www.idref.fr/095666133</idno>
              <idno type="VIAF">https://viaf.org/viaf/195021711</idno>
              <idno type="ISNI">http://isni.org/isni/0000000431168906</idno>
              <affiliation ref="#struct-444080"/>
              <affiliation ref="#struct-477534"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Denis</forename>
                <surname>Guilloteau</surname>
              </persName>
              <idno type="halauthorid">639189-0</idno>
              <affiliation ref="#struct-53727"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Françoise</forename>
                <surname>Kraeber-Bodéré</surname>
              </persName>
              <email type="md5">9480af72d9b9633f9778af8a03cc9020</email>
              <email type="domain">chu-nantes.fr</email>
              <idno type="idhal" notation="numeric">1335905</idno>
              <idno type="halauthorid" notation="string">492844-1335905</idno>
              <idno type="ORCID">https://orcid.org/0000-0002-3417-0759</idno>
              <idno type="IDREF">https://www.idref.fr/073740314</idno>
              <affiliation ref="#struct-444080"/>
            </author>
            <editor role="depositor">
              <persName>
                <forename>Elizabeth</forename>
                <surname>Bernardo</surname>
              </persName>
              <email type="md5">373b15f895425e6af21c3cffa325a784</email>
              <email type="domain">univ-nantes.fr</email>
            </editor>
            <funder ref="#projanr-37462"/>
            <funder ref="#projanr-26984"/>
            <funder>French National Agency for Research called “Investissementsd’Avenir”, Labex IRON no ANR-11-LABX-0018-01 and EquipexArronaxPlus no ANR-11-EQPX-0004.</funder>
          </titleStmt>
          <editionStmt>
            <edition n="v1" type="current">
              <date type="whenSubmitted">2017-02-09 15:53:39</date>
              <date type="whenModified">2025-09-17 11:06:02</date>
              <date type="whenReleased">2017-02-13 14:57:46</date>
              <date type="whenProduced">2017-01-11</date>
              <date type="whenEndEmbargoed">2017-02-10</date>
              <ref type="file" target="https://inserm.hal.science/inserm-01463679v1/document">
                <date notBefore="2017-02-10"/>
              </ref>
              <ref type="file" subtype="greenPublisher" n="1" target="https://inserm.hal.science/inserm-01463679v1/file/Barbet2017Eq13.pdf" id="file-1463679-1534866">
                <date notBefore="2017-02-10"/>
              </ref>
              <ref type="externalLink" target="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5225142"/>
            </edition>
            <respStmt>
              <resp>contributor</resp>
              <name key="326726">
                <persName>
                  <forename>Elizabeth</forename>
                  <surname>Bernardo</surname>
                </persName>
                <email type="md5">373b15f895425e6af21c3cffa325a784</email>
                <email type="domain">univ-nantes.fr</email>
              </name>
            </respStmt>
          </editionStmt>
          <publicationStmt>
            <distributor>CCSD</distributor>
            <idno type="halId">inserm-01463679</idno>
            <idno type="halUri">https://inserm.hal.science/inserm-01463679</idno>
            <idno type="halBibtex">barbet:inserm-01463679</idno>
            <idno type="halRefHtml">&lt;i&gt;Frontiers in Medicine&lt;/i&gt;, 2017, 3, pp.74. &lt;a target="_blank" href="https://dx.doi.org/10.3389/fmed.2016.00074"&gt;&amp;#x27E8;10.3389/fmed.2016.00074&amp;#x27E9;&lt;/a&gt;</idno>
            <idno type="halRef">Frontiers in Medicine, 2017, 3, pp.74. &amp;#x27E8;10.3389/fmed.2016.00074&amp;#x27E9;</idno>
            <availability status="restricted">
              <licence target="https://about.hal.science/hal-authorisation-v1/">HAL Authorization<ref corresp="#file-1463679-1534866"/></licence>
            </availability>
          </publicationStmt>
          <seriesStmt>
            <idno type="stamp" n="INSERM">INSERM - Institut national de la santé et de la recherche médicale</idno>
            <idno type="stamp" n="UNIV-NANTES">Université de Nantes</idno>
            <idno type="stamp" n="UNIV-TOURS">Université François Rabelais</idno>
            <idno type="stamp" n="CNRS">CNRS - Centre national de la recherche scientifique</idno>
            <idno type="stamp" n="UNIV-ANGERS">Université d'Angers</idno>
            <idno type="stamp" n="CRCINA" corresp="INSERM">Centre de Recherche en Cancérologie et Immunologie Nantes Angers</idno>
            <idno type="stamp" n="ANR">ANR</idno>
            <idno type="stamp" n="NANTES-UNIVERSITE">Nantes Université</idno>
            <idno type="stamp" n="UNIV-NANTES-AV2022">Université de Nantes</idno>
            <idno type="stamp" n="UFR-MEDECINE-NANTES">UFR de médecine - Nantes Université</idno>
            <idno type="stamp" n="IBRAIN">Imaging Brain &amp; Neuropsychiatry</idno>
          </seriesStmt>
          <notesStmt>
            <note type="audience" n="2">International</note>
            <note type="popular" n="0">No</note>
            <note type="peer" n="1">Yes</note>
          </notesStmt>
          <sourceDesc>
            <biblStruct>
              <analytic>
                <title xml:lang="en">Editorial: innovative radiopharmaceuticals in oncology and Neurology</title>
                <author role="aut">
                  <persName>
                    <forename type="first">Jacques</forename>
                    <surname>Barbet</surname>
                  </persName>
                  <idno type="halauthorid">301813-0</idno>
                  <affiliation ref="#struct-545604"/>
                  <affiliation ref="#struct-477534"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Nicolas</forename>
                    <surname>Arlicot</surname>
                  </persName>
                  <idno type="halauthorid">719895-0</idno>
                  <affiliation ref="#struct-53727"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Marie-Hélène</forename>
                    <surname>Gaugler</surname>
                  </persName>
                  <email type="md5">d355d2436b955635be02313277c2dc81</email>
                  <email type="domain">univ-nantes.fr</email>
                  <idno type="idhal" notation="string">marie-helene-gaugler</idno>
                  <idno type="idhal" notation="numeric">1444588</idno>
                  <idno type="halauthorid" notation="string">1038911-1444588</idno>
                  <idno type="ORCID">https://orcid.org/0000-0003-2932-9443</idno>
                  <affiliation ref="#struct-477534"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Michel</forename>
                    <surname>Chérel</surname>
                  </persName>
                  <email type="md5">faa80347e497f8eeeb8a12647a37d2d5</email>
                  <email type="domain">univ-nantes.fr</email>
                  <idno type="idhal" notation="string">michel-cherel</idno>
                  <idno type="idhal" notation="numeric">752010</idno>
                  <idno type="halauthorid" notation="string">34807-752010</idno>
                  <idno type="ORCID">https://orcid.org/0000-0001-6347-6848</idno>
                  <idno type="IDREF">https://www.idref.fr/095666133</idno>
                  <idno type="VIAF">https://viaf.org/viaf/195021711</idno>
                  <idno type="ISNI">http://isni.org/isni/0000000431168906</idno>
                  <affiliation ref="#struct-444080"/>
                  <affiliation ref="#struct-477534"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Denis</forename>
                    <surname>Guilloteau</surname>
                  </persName>
                  <idno type="halauthorid">639189-0</idno>
                  <affiliation ref="#struct-53727"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Françoise</forename>
                    <surname>Kraeber-Bodéré</surname>
                  </persName>
                  <email type="md5">9480af72d9b9633f9778af8a03cc9020</email>
                  <email type="domain">chu-nantes.fr</email>
                  <idno type="idhal" notation="numeric">1335905</idno>
                  <idno type="halauthorid" notation="string">492844-1335905</idno>
                  <idno type="ORCID">https://orcid.org/0000-0002-3417-0759</idno>
                  <idno type="IDREF">https://www.idref.fr/073740314</idno>
                  <affiliation ref="#struct-444080"/>
                </author>
              </analytic>
              <monogr>
                <idno type="halJournalId" status="VALID">104429</idno>
                <idno type="issn">2296-858X</idno>
                <title level="j">Frontiers in Medicine</title>
                <imprint>
                  <publisher>Frontiers media</publisher>
                  <biblScope unit="volume">3</biblScope>
                  <biblScope unit="pp">74</biblScope>
                  <date type="datePub">2017-01-11</date>
                </imprint>
              </monogr>
              <idno type="doi">10.3389/fmed.2016.00074</idno>
              <idno type="pubmed">28123998</idno>
              <idno type="pubmedcentral">PMC5225142</idno>
            </biblStruct>
          </sourceDesc>
          <profileDesc>
            <langUsage>
              <language ident="en">English</language>
            </langUsage>
            <textClass>
              <keywords scheme="author">
                <term xml:lang="en">targeted radionuclide therapy</term>
                <term xml:lang="en">multimodality imaging</term>
                <term xml:lang="en">theranostic</term>
                <term xml:lang="en">PEt imaging</term>
                <term xml:lang="en">pretargeted radioimmunotherapy</term>
                <term xml:lang="en">radiopharmaceuticals</term>
              </keywords>
              <classCode scheme="halDomain" n="sdv.can">Life Sciences [q-bio]/Cancer</classCode>
              <classCode scheme="halTypology" n="ART">Journal articles</classCode>
              <classCode scheme="halOldTypology" n="ART">Journal articles</classCode>
              <classCode scheme="halTreeTypology" n="ART">Journal articles</classCode>
            </textClass>
            <abstract xml:lang="en">
              <p>Editorial on the Research Topic Innovative Radiopharmaceuticals in Oncology and Neurology Personalized medicine is presented as the future of patient care. Nuclear Medicine will play a major role in the selection of patients for targeted therapies and in early therapy assessment with the investigation of phenotypes and functions using sensitive and specific SPECT and PET imaging techniques and theranostic approaches. Nuclear Medicine is already a key in the development of new therapies and targeted radionuclide therapy provides efficacious treatment modalities against cancer. An incredible amount of innovation is related to the use of a variety of radionuclides, new or improved multimodality imaging devices, and numbers of recently marketed radiopharmaceuticals in all medical domains and particularly cardiology, neurology, and oncology. In this context, a network of laboratories and Nuclear Medicine departments, the IRON Laboratory of Excellence (Labex), has been set as part of the French " Investissements d' Avenir " program to help translating innovative radiopharmaceuticals into clinical testing by a multidisciplinary approach from the production of radionuclides using cyclotrons, to basic studies of targets and ligands, clinical trials, and assessment of the societal impacts of innovation in medicine in neurology and oncology. To foster communication between scientists, inside the Labex and with the international community, a series of highly specialized international " Nuclear Technologies for Health Symposia " has been organized annually, with the most recent edition, the third, held in Nantes, France, on March 10–11, 2015. Plenary lectures given by distinguished speakers (Hank Kung, Philadelphia, PA, USA, Tom Bäck, Gothenburg, Sweden, Otto Boerman, Nijmegen, The Netherlands, Franck Bruchertseifer, Karlsruhe, Germany, and Claire Tabouret-Viaud, Geneva, Switzerland) addressed the state of the arts and new developments in the use of radioactivity and radiopharmaceuticals for multimodality imaging and therapy. The latest achievements in clinical nuclear medicine, science, and technology were discussed during interactive oral and poster sessions. Selected talks were organized in four sessions: innovative tracers in neurology: from bench to bedside, multimodality imaging, theranostic in nuclear medicine, and targeted radionuclide therapy. After the meeting, 12 papers were published in the Nuclear Medicine topic open by Frontiers in Medicine. These papers are representative of current research and development in Nuclear Medicine.</p>
            </abstract>
          </profileDesc>
        </biblFull>
      </listBibl>
    </body>
    <back>
      <listOrg type="structures">
        <org type="laboratory" xml:id="struct-545604" status="OLD">
          <orgName>GIP ARRONAX [Nantes]</orgName>
          <orgName type="acronym">GIP ARRONAX</orgName>
          <date type="start">2008-01-01</date>
          <date type="end">2021-12-31</date>
          <desc>
            <address>
              <addrLine>Nantes St Herblain</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.arronax-nantes.fr/gip-arronax/</ref>
          </desc>
          <listRelation>
            <relation active="#struct-93263" type="direct"/>
          </listRelation>
        </org>
        <org type="laboratory" xml:id="struct-477534" status="OLD">
          <idno type="IdRef">189169206</idno>
          <idno type="RNSR">200816529L</idno>
          <orgName>Centre de Recherche en Cancérologie et Immunologie Nantes-Angers</orgName>
          <orgName type="acronym">CRCINA</orgName>
          <date type="start">2017-01-01</date>
          <date type="end">2021-12-31</date>
          <desc>
            <address>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.crcina.org/</ref>
          </desc>
          <listRelation>
            <relation active="#struct-74911" type="direct"/>
            <relation active="#struct-303623" type="direct"/>
            <relation active="#struct-441569" type="direct"/>
            <relation active="#struct-474972" type="direct"/>
            <relation active="#struct-531638" type="direct"/>
            <relation active="#struct-93263" type="indirect"/>
          </listRelation>
        </org>
        <org type="laboratory" xml:id="struct-53727" status="VALID">
          <idno type="IdRef">228879965</idno>
          <idno type="RNSR">201220230S</idno>
          <idno type="ROR">https://ror.org/01eem7c55</idno>
          <orgName>Imaging, Brain &amp; Neuropsychiatry</orgName>
          <orgName type="acronym">iBraiN</orgName>
          <date type="start">1988-01-01</date>
          <desc>
            <address>
              <addrLine>10 Bd TonnelléBât. Thérèse Planiol37032 Tours Cedex 1</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://ibrain.univ-tours.fr/</ref>
          </desc>
          <listRelation>
            <relation name="UMR U1253" active="#struct-300298" type="direct"/>
            <relation name="UMR U1253" active="#struct-303623" type="direct"/>
          </listRelation>
        </org>
        <org type="institution" xml:id="struct-444080" status="VALID">
          <idno type="ROR">https://ror.org/01m6as704</idno>
          <orgName>Institut de Cancérologie de l'Ouest [Angers/Nantes]</orgName>
          <orgName type="acronym">UNICANCER/ICO</orgName>
          <desc>
            <address>
              <addrLine>15, rue André Boquel - 49055 Angers cedex 02</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.institut-cancerologie-ouest.com/</ref>
          </desc>
          <listRelation>
            <relation active="#struct-502406" type="direct"/>
          </listRelation>
        </org>
        <org type="institution" xml:id="struct-93263" status="OLD">
          <idno type="IdRef">026403447</idno>
          <idno type="ROR">https://ror.org/03gnr7b55</idno>
          <orgName>Université de Nantes</orgName>
          <orgName type="acronym">UN</orgName>
          <date type="end">2021-12-31</date>
          <desc>
            <address>
              <addrLine>1, quai de Tourville - BP 13522 - 44035 Nantes cedex 1</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.univ-nantes.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-74911" status="VALID">
          <idno type="IdRef">026402920</idno>
          <idno type="ISNI">0000000122483363</idno>
          <idno type="ROR">https://ror.org/04yrqp957</idno>
          <orgName>Université d'Angers</orgName>
          <orgName type="acronym">UA</orgName>
          <date type="start">1971-10-25</date>
          <desc>
            <address>
              <addrLine>Université d'Angers - 40 Rue de Rennes, BP 73532 - 49035 Angers CEDEX 01</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.univ-angers.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-303623" status="VALID">
          <idno type="IdRef">026388278</idno>
          <idno type="ROR">https://ror.org/02vjkv261</idno>
          <orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
          <orgName type="acronym">INSERM</orgName>
          <desc>
            <address>
              <addrLine>101, rue de Tolbiac, 75013 Paris</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.inserm.fr</ref>
          </desc>
        </org>
        <org type="regroupinstitution" xml:id="struct-441569" status="VALID">
          <idno type="IdRef">02636817X</idno>
          <idno type="ISNI">0000000122597504</idno>
          <idno type="ROR">https://ror.org/02feahw73</idno>
          <orgName>Centre National de la Recherche Scientifique</orgName>
          <orgName type="acronym">CNRS</orgName>
          <date type="start">1939-10-19</date>
          <desc>
            <address>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.cnrs.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-474972" status="VALID">
          <idno type="IdRef">034926445</idno>
          <idno type="ROR">https://ror.org/05c1qsg97</idno>
          <idno type="Wikidata">Q2945767</idno>
          <orgName>Centre Hospitalier Universitaire de Nantes = Nantes University Hospital</orgName>
          <orgName type="acronym">CHU Nantes</orgName>
          <desc>
            <address>
              <addrLine>1 Place Alexis-Ricordeau, 44000 Nantes</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.chu-nantes.fr</ref>
          </desc>
        </org>
        <org type="regrouplaboratory" xml:id="struct-531638" status="OLD">
          <idno type="IdRef">076954927</idno>
          <orgName>Université de Nantes - UFR de Médecine et des Techniques Médicales</orgName>
          <orgName type="acronym">UFR MEDECINE</orgName>
          <date type="end">2021-12-31</date>
          <desc>
            <address>
              <addrLine>1 rue Gaston Veil BP 53508 44035 NANTES Cedex 1</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.medecine.univ-nantes.fr</ref>
          </desc>
          <listRelation>
            <relation active="#struct-93263" type="direct"/>
          </listRelation>
        </org>
        <org type="institution" xml:id="struct-300298" status="VALID">
          <idno type="IdRef">026404478</idno>
          <idno type="ISNI">0000000121608742</idno>
          <idno type="ROR">https://ror.org/02wwzvj46</idno>
          <orgName>Université de Tours</orgName>
          <orgName type="acronym">UT</orgName>
          <date type="start">1970-12-17</date>
          <desc>
            <address>
              <addrLine>60 rue du Plat d'Étain, 37020 Tours cedex 1</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.univ-tours.fr</ref>
          </desc>
        </org>
        <org type="regroupinstitution" xml:id="struct-502406" status="VALID">
          <orgName>UNICANCER</orgName>
          <desc>
            <address>
              <addrLine>101, rue de Tolbiac, 75654 Paris Cedex 13</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.unicancer.fr/</ref>
          </desc>
        </org>
      </listOrg>
      <listOrg type="projects">
        <org type="anrProject" xml:id="projanr-37462" status="VALID">
          <idno type="anr">ANR-11-EQPX-0004</idno>
          <orgName>ARRONAXPLUS</orgName>
          <desc>Nucléaire pour la Santé</desc>
          <date type="start">2011</date>
        </org>
        <org type="anrProject" xml:id="projanr-26984" status="VALID">
          <idno type="anr">ANR-11-LABX-0018</idno>
          <orgName>IRON</orgName>
          <desc>Radiopharmaceutiques Innovants en Oncologie et Neurologie</desc>
          <date type="start">2011</date>
        </org>
      </listOrg>
    </back>
  </text>
</TEI>